GSE162892 ISOX 3 v 5 human dn (Gene Set)

Analyze

Playbook Workflow Builder
Playbook Workflow Builder: Gene Set Enrichment

Perform Gene Set Enrichment with this gene set against Common Fund program's gene sets, identifying significant overlaps using a pre-built PWB workflow. Run the workflow with GSE162892_ISOX_3_v_5_human_dn.

GeneSetCart
GeneSetCart

GeneSetCart helps you to fetch gene sets from various data sources, augment, combine with set operations, visualize and analyze these gene sets in a single session. Start a new session with GSE162892_ISOX_3_v_5_human_dn.

CFDE-GSE
CFDE Gene Set Enrichment (GSE)

CFDE-GSE illuminates connections between the input gene set and various CF gene sets that overlap with the queried gene set. Query CFDE-GSE with GSE162892_ISOX_3_v_5_human_dn.

Playbook Workflow Builder
Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with GSE162892_ISOX_3_v_5_human_dn.

Results found

Linked to

 

Label

Description

 

Gene

small nucleolar RNA host gene 5

Gene

ribosomal protein SA 2

Gene

cutA divalent cation tolerance like, pseudogene

Gene

long intergenic non-protein coding RNA 662

Gene

MT-CO2 pseudogene 12

Gene

long intergenic non-protein coding RNA 2693

Gene

zinc finger protein 839 pseudogene

Gene

HERC2 pseudogene 2

Gene

ribosomal protein S2 pseudogene 5

Gene

NIPBL divergent transcript

  • Gene

    small nucleolar RNA host gene 5


  • Gene

    ribosomal protein SA 2


  • Gene

    cutA divalent cation tolerance like, pseudogene


  • Gene

    long intergenic non-protein coding RNA 662


  • Gene

    MT-CO2 pseudogene 12


  • Gene

    long intergenic non-protein coding RNA 2693


  • Gene

    zinc finger protein 839 pseudogene


  • Gene

    HERC2 pseudogene 2


  • Gene

    ribosomal protein S2 pseudogene 5


  • Gene

    NIPBL divergent transcript

  • DISPLAY PER PAGE
    This repository is under review for potential modification in compliance with Administration directives.